Last updated on November 2017

C diffense - Clostridium Difficile Vaccine Trial


Brief description of study

C diffense - Clostridium Difficile Vaccine Trial

Detailed Study Description

If you answer "Yes" to the Eligiblity Criteria, you may be at risk for a serious healthcare associated infection from a bacterium called Clostridium Difficile (C. diff)

Sanofi Pasteur and this research site are conducting a clinical research study for an investigational vaccine that may protect at risk individuals like yourself from Clostridium Difficile (C. diff) infections.

Clinical Study Identifier: TX81327

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Endeavor Clinical Trials, PA

Endeavor Clinical Trials, PA
San Antonio, TX USA
  Connect »